Literature DB >> 12603086

Changes in brain intracellular pH and membrane phospholipids on oxygen therapy in hypoxic patients with chronic obstructive pulmonary disease.

G Hamilton1, R Mathur, J M Allsop, D M Forton, N S Dhanjal, R J Shaw, S D Taylor-Robinson.   

Abstract

Chronic hypoxia due to chronic obstructive pulmonary disease (COPD) constitutes a stress to cerebral metabolic homeostasis. Previous studies using phosphorus-31 magnetic resonance spectroscopy (31P MRS) have suggested that the brains of such patients utilize anaerobic glycolysis, which in neonatal, animal, and in vitro studies is associated with a protective intracellular alkalosis. To identify such a compensatory intracellular alkalosis in hypoxic COPD patients, in vivo cerebral 31P MRS was performed in eight patients and eight controls. The mean intracellular pH (pHi) in patients with COPD was similar to that of age-matched controls, but decreased in the patients with COPD by a mean pHi of 0.02 (p = 0.04), following supplemental oxygen. There was no change in cerebral pHi in normal subjects following oxygen administration. The broadband component of the MR spectrum increased in all the patients with COPD (p = 0.01), suggesting altered phospholipid membrane fluidity in the brain associated with the change in pHi following oxygen administration. The change in the broadband resonance was strongly correlated with the change in pHi (r = -0.68, p = 0.014). This study suggests that patients with COPD exhibit a compensatory change in pHi and abnormalities in cerebral membrane phospholipid conformation in the face of chronic hypoxia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603086     DOI: 10.1023/a:1021938926807

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  4 in total

1.  pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.

Authors:  Myriam M Chaumeil; Julien Valette; Céline Baligand; Emmanuel Brouillet; Philippe Hantraye; Gilles Bloch; Véronique Gaura; Amandine Rialland; Pierre Krystkowiak; Christophe Verny; Philippe Damier; Philippe Remy; Anne-Catherine Bachoud-Levi; Pierre Carlier; Vincent Lebon
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-29       Impact factor: 6.200

Review 2.  The neuroprotective effects of oxygen therapy in Alzheimer's disease: a narrative review.

Authors:  Cui Yang; Qiu Yang; Yang Xiang; Xian-Rong Zeng; Jun Xiao; Wei-Dong Le
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

3.  Phosphorus-31 brain MR spectroscopy in women during and after pregnancy compared with nonpregnant control subjects.

Authors:  Anita Holdcroft; Lisa Hall; Gavin Hamilton; Serena J Counsell; Graeme M Bydder; Jimmy D Bell
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

4.  Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans.

Authors:  Basant K Puri; Serena J Counsell; Brian M Ross; Gavin Hamilton; Marcelo G Bustos; Ian H Treasaden
Journal:  BMC Psychiatry       Date:  2008-04-17       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.